logo
更新:2024-05-11
临床科学经理/高级经理-人才储备
25-45万
北京朝阳区  | 硕士  | 社招
去申请
收藏
举报
职位详情
五险一金
年终奖金
绩效奖金
带薪年假
年度旅游
子女福利
定期体检
Primary Responsibilities:

1、Contribute to clinical development strategies and develop trial protocol for phase 1~3 based on regulatory requirement and business needs to generate clinical data for new product approval and strengthen product life cycle management

2、Take medical responsibility in clinical trial execution with high scientific and ethical standards to ensure the quality of clinical trial for regulatory submission and promotion use

3、Generate key clinical documents and interact with Health Authority to achieve timely CTA/NDA submission and approval

4、Build up relationship with KOLs/Investigators to influence them to accommodate and overcome medical or treatment procedure barriers in clinical programs to facilitate trial execution and advocate company’s products

5、Provide medical expertise in protocol review within relevant filed to contribute global development

6、Be medical representative in routine communication with Health authority

7、Coach medical scientists regarding the general and professional competencies, skills and knowledge in order for them to accomplish their accountabilities

Qualifications:

1、3-5 years of clinical development experience (at least as clinical research physician for 3 years) in global pharmaceutical

2、Pharmaceutical experience in NDAs, preparing for Authority Meetings in the therapeutic areas, Phase 1-3 best practices and procedures, Standard Operating Procedure development, and working with CROs/vendor

3、Excellent communication and presentation skills

4、Work independently within expertise

5、Excellent collaboration in a cross functional team setting

6、Ability to quickly adjust to new situations in project management

7、Proficiency in both written & spoken English

8、Master degree or above in clinical medicine

其他信息


所属部门:--请选择部门--
工作地址
北京-朝阳区SK大厦
公司介绍
卫材在中国企业隶属于卫材株式会社,卫材株式会社是一家以研究开发医药产品为主的跨国公司,总部设在日本东京,中国区总部位于上海。
卫材自上世纪90年代初进入中国市场以来顺利发展壮大,在中国总注册资本10,854万美金,目前形成了以卫材(中国)投资有限公司为资控管理,以卫材(中国)药业有限公司、卫材(辽宁)制药有限公司、卫材(苏州)贸易有限公司、卫材(香港)有限公司为业务支撑的发展模式,并投资成立合资公司京颐卫享(上海)健康产业发展有限公司。以神经科学领域、肿瘤(特药)领域、消化肝病领域为重点领域,拓展仿制药领域和互联网+医疗领域,多达数十种药品在中国销售的发展规模。
卫材所有在中国企业秉承hhc(human health care,关心人类健康)企业理念,以Compliance(遵守道德)为行为准则,以GMP为质量标准,向患者及其家属提供高质、环保、安全和满意的产品和服务。我们的目标是发展成为 "hhc理念+生态系统"(hhceco),以帮助人民从健康时期到生命终点都能够实现他们最充实的生活。
同时,积极承担企业社会责任,2020年为抗击新冠肺炎疫情累计捐赠超过1500万元的现金和医疗物资;自2000年至今,已奖励、资助医药类高等院校学生2900余名,总计奖励资助金额超过1000万元;自2013年至今,与人口福利基金会合作“记得我爱你黄手环”项目捐赠金额超过500万元,已惠及25万高风险的老年痴呆患者;自2014年至2019年,通过“卫生三下乡”活动捐赠金额近300万元的医药品;到目前为止,与中国初级卫生保健基金会合作向肿瘤患者和家庭无偿提供了超过20亿元药品,解决患者的家庭负担,极大提升了患者使用创新药的可及性和可负担性,并连续数年获得“上海市文明单位”、“中国杰出雇主”、 “大苏州最佳雇主”、“中国医药工业百强”、“推进医学公益践行企业使命”年度企业等荣誉称号。
若用人单位提供虚假招聘信息,以担保或其他任何名义收取财物,扣押或以保管为名索要证件,都属于违法行为,应当提高警惕。
发布于猎聘网